Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Chronic kidney disease

Levels of phosphorus and patient outcomes

Nature Reviews Nephrology volume 7, pages 428–430 (2011)Cite this article

Subjects

Clinical practice guidelines recommend target serum levels for phosphorus, calcium and parathyroid hormone in patients with chronic kidney disease. However, a recent meta-analysis has found that only levels of phosphorus seem to be associated with the risk of death in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Palmer, S. C. et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305, 1119–1127 (2011).

    Article  CAS  Google Scholar 

  2. Dhingra, R. et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch. Intern. Med. 167, 879–885 (2007).

    Article  CAS  Google Scholar 

  3. Singh, A. K. et al. Correction of anemia with epoetin alfa in chronic kidney disease. N. Engl. J. Med. 355, 2085–2098 (2006).

    Article  CAS  Google Scholar 

  4. Veritas Medicine Clinical Study Report PR00-06-014 (CHOIR) [online], (2006).

  5. Phrommintikul, A., Haas, S. J., Elsik, M. & Krum, H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369, 381–388 (2007).

    Article  CAS  Google Scholar 

  6. Palmer, S. C. et al. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann. Intern. Med. 153, 23–33 (2010).

    Article  Google Scholar 

  7. Miskulin, D. et al. Key comorbid conditions that are predictive of survival among hemodialysis patients. Clin. J. Am. Soc. Nephrol. 4, 1818–1826 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chronic Disease Research Group, 914 South 8th Street, Suite S-406, Minneapolis, 55404, MN, USA

    Robert N. Foley

Authors
  1. Robert N. Foley
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foley, R. Levels of phosphorus and patient outcomes. Nat Rev Nephrol 7, 428–430 (2011). https://doi.org/10.1038/nrneph.2011.87

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2011.87

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing